Outspoken Oncology

Chadi welcomes back Rafael Fonseca, MD, interim executive director, Mayo Clinic Comprehensive Cancer Center, to discuss the steps that large cancer centers should take to protect their patients as well as staff from COVID-19 infection, specific measures that Mayo Clinic has taken for developing in-house testing, and more.

Chadi welcomes back Emily Landon, MD, executive medical director of infection prevention and control, University of Chicago, to provide updates on issues of state-funded COVID-19 testing and laboratory resources, management considerations for immuno-compromised patients in oncology clinics, importance of social distancing and isolation to limit the strain on local health systems, and more.

Chadi welcomes back Emily Landon, MD, executive medical director of infection prevention and control, University of Chicago, to provide updates on issues of state-funded COVID-19 testing and laboratory resources, management considerations for immuno-compromised patients in oncology clinics, importance of social distancing and isolation to limit the strain on local health systems, and more.

David Mitchell, president and founder of Patients for Affordable Drugs, discusses the importance of reducing out-of-pocket costs and premiums for patients, the need for an entity to recommend costs for novel therapies to payers, pieces of legislation that address drug patent "abuse" on the part of manufacturers, and more.

David Mitchell, president and founder of Patients for Affordable Drugs, discusses the importance of reducing out-of-pocket costs and premiums for patients, the need for an entity to recommend costs for novel therapies to payers, pieces of legislation that address drug patent "abuse" on the part of manufacturers, and more.

Emily Landon, MD, executive medical director of infection prevention and control, University of Chicago, breaks down current exposure risk and mortality rates of COVID-19, preventative steps to avoid exposure, and promising therapies on the horizon.

Emily Landon, MD, executive medical director of infection prevention and control, University of Chicago, breaks down current exposure risk and mortality rates of COVID-19, preventative steps to avoid exposure, and promising therapies on the horizon.

Rafael Fonseca, MD, and Saurabh Jha, MD, debate the benefits and disadvantages of a third-party vs single payer system, whether Medicare has been a successful program for qualifying patients. and the fairness of judging the health care system based on life expectancy.

To read more about our host Chadi Nabhan and access exclusive materials and information about guests, visit journalofclinicalpathways.com/podcasts/outspoken-oncology.

Journal of Clinical Pathways is the exclusive producer of the Outspoken Oncology podcast.

Rafael Fonseca, MD, and Saurabh Jha, MD, debate the benefits and disadvantages of a third-party vs single payer system, whether Medicare has been a successful program for qualifying patients. and the fairness of judging the health care system based on life expectancy.

To read more about our host Chadi Nabhan and access exclusive materials and information about guests, visit journalofclinicalpathways.com/podcasts/outspoken-oncology.

Journal of Clinical Pathways is the exclusive producer of the Outspoken Oncology podcast.

Sayeh Nikpay, PhD, MPH, Vanderbilt University School of Medicine, explains the origins of 340B, how safety net clinics as well as large hospitals became participants in the program, and the possibility of getting rid of the program altogether.